CLIMARA 25 PATCH

देश: कनाडा

भाषा: अंग्रेज़ी

स्रोत: Health Canada

सक्रिय संघटक:

ESTRADIOL (ESTRADIOL HEMIHYDRATE)

थमां उपलब्ध:

BAYER INC

ए.टी.सी कोड:

G03CA03

INN (इंटरनेशनल नाम):

ESTRADIOL

डोज़:

25MCG

फार्मास्यूटिकल फॉर्म:

PATCH

रचना:

ESTRADIOL (ESTRADIOL HEMIHYDRATE) 25MCG

प्रशासन का मार्ग:

TRANSDERMAL

पैकेज में यूनिट:

4

प्रिस्क्रिप्शन प्रकार:

Prescription

चिकित्सीय क्षेत्र:

ESTROGENS

उत्पाद समीक्षा:

Active ingredient group (AIG) number: 0106457033; AHFS:

प्राधिकरण का दर्जा:

APPROVED

प्राधिकरण की तारीख:

2007-03-08

उत्पाद विशेषताएं

17β)
·
·
·
·
·
·
·
·
·
·
·
·
·
·
=
·
·
·
·
·
·
·
·
·
·
·
·
–
≥
–
≥
–
≥
*
John’s wort.
·
·
·
·
·
17β. Upon application to
17β, the major estrogenic hormone secreted by the human ovary.
17β is the predominant estrogen produced by the ovaries in
premenopausal women.
17β), and provides controlled delivery of estradiol
17β,
17β), and provides controlled delivery of estradiol
17β, 0.05
17β), and provides controlled delivery of estradiol
17β,
17β)
PART II: SCIENTIFIC INFORMATION
β
2 •
–
–
–
–
–
–
–
–
–
–
–
–
17β per day) is not approved for
completed the study. Both CLIMARA 50 and CLIMARA 100 were
significantly (p ≤ 0.05) more
efficacy parameters. Statistically significant (p ≤ 0.05) treatment
effects with both doses were
–
change from baseline significantly (p≤0.05) less for placebo group
than for the CLIMARA 50 and CLIMARA 100
Mean score significantly (p≤0.05) less for the placebo group than
for the CLIMARA 50 and CLIMARA 100
CLIMARA 50 and CLIMARA 100 statistically significant at p ≤ 0.05.
–
Mean score significantly (p ≤ 0.05) less for the for the CLIMARA 50
group than for the CLIMARA 100
Mean score significantly (p ≤ 0.05) less for the for the CLIMARA 50
group than for the CLIMARA 100 group, and, mean score
significantly (p ≤ 10.05) less for the
–
–
–
–
–
–
Patient’s Assessment
Investigator’s Assessment
Patient’s Assessment
Investigator’s Assessment
–
–
–
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
<0.0001‡
<0.0001 ‡
0.0001 ‡
<0.0001‡
<0.0001 ‡
†
‡ p < 0.05
17β per day) is not approved for sale in Canada.
–
†
†
†
†
†
†
†
†
†
†
–
†
†
†
†
†
†
†
†
†
†
0.0141 ‡
<0.0001 ‡
0.0001 ‡
<0.0001 ‡
<0.0001 ‡
†
‡ p < 0.05
17β per day) is not approved for sale in Canada.
–
crease in bone mineral density at the hip (trochanteric region,
Ward’s triangle, femoral neck) and spine
Ward’s Triang